Fresenius Medical Care AG (WBO:FME) Cyclically Adjusted PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:FME Fresenius Medical Care AG WBO:FME
66 GF Score
Price €38.64
GF Value €42.23
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Fresenius Medical Care AG  (WBO:FME) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Fresenius Medical Care AG Cyclically Adjusted PS Ratio Related Terms


Fresenius Medical Care AG Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG Cyclically Adjusted PS Ratio Chart

Fresenius Medical Care AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.06 0.50 0.58 0.64 0.58

Fresenius Medical Care AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.70 0.64 0.58 0.54 0.55

WBO:FME vs HCA, THC, EHC: Cyclically Adjusted PS Ratio Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Cyclically Adjusted PS Ratio falls into.


WBO:FME
66GF Score
Fresenius Medical Care AG WBO:FME
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius Medical Care AG Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Fresenius Medical Care AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Fresenius Medical Care AG's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=18.107/131.3638*131.3638
=18.107

Current CPI (Jun. 2026) = 131.3638.

Fresenius Medical Care AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 13.735 101.017 17.861
201612 14.365 101.217 18.644
201703 14.826 101.417 19.204
201706 14.552 102.117 18.720
201709 14.112 102.717 18.048
201712 14.289 102.617 18.292
201803 12.931 102.917 16.505
201806 13.713 104.017 17.318
201809 13.204 104.718 16.564
201812 13.993 104.217 17.638
201903 13.476 104.217 16.986
201906 14.313 105.718 17.785
201909 14.660 106.018 18.165
201912 15.251 105.818 18.933
202003 15.057 105.718 18.710
202006 15.555 106.618 19.165
202009 15.060 105.818 18.696
202012 15.023 105.518 18.703
202103 14.369 107.518 17.556
202106 14.741 108.486 17.850
202109 15.151 109.435 18.187
202112 15.838 110.384 18.848
202203 15.519 113.968 17.888
202206 16.226 115.760 18.413
202209 17.369 118.818 19.203
202212 17.031 119.345 18.746
202303 16.033 122.402 17.207
202306 16.445 123.140 17.543
202309 16.823 124.195 17.794
202312 17.000 123.773 18.043
202403 16.102 125.038 16.917
202406 16.245 125.882 16.952
202409 16.223 126.198 16.887
202412 17.330 127.041 17.920
202503 16.637 127.779 17.104
202506 16.331 128.412 16.706
202509 16.723 129.255 16.996
202512 17.733 129.361 18.008
202603 16.756 131.258 16.769
202606 18.107 131.364 18.107

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Fresenius Medical Care AG (WBO:FME) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued. The current stock price of €38.64 is trading 8.5% below its estimated GF Value™ of €42.23. GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.

Key valuation signals for WBO:FME:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €42.23 vs. price of €38.64 (8.5% below fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the WBO:FME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
66GF Score

Get the complete analysis for WBO:FME

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€38.64
Price
€42.23
GF Value